Commercial coverage
Does Cigna cover Rybelsus?
Rybelsus (semaglutide (oral)) for type 2 diabetes — the Cigna prior-authorization rule, source-cited.
Cigna Rybelsus PA criteria
Per policy IP0701 (Employer Plans: Standard/Performance, Value/Advantage, Legacy, Total Savings PDLs; covers Bydureon BCise, Byetta/exenatide, Mounjaro, Ozempic tablets+injection, Rybelsus, Trulicity, Victoza/liraglutide).
Approval requires ONLY a diagnosis of Type 2 diabetes mellitus (documentation required); for brand Byetta/Victoza only, also a preferred-product step (tried bioequivalent generic).
NO metformin step therapy and NO A1C threshold.
Approve for 1 year.
Not covered: weight loss without T2DM, Type 1 diabetes, prediabetes/prevention, metabolic syndrome, concurrent use of two GLP-1/GLP-1-GIP agonists.
Source: Cigna Coverage Policies IP0206 (Weight Loss GLP-1) & IP0701 (Diabetes GLP-1 Employer Plans). View cited GLP-1 policy reference →
Frequently asked
- Does Cigna cover Rybelsus for type 2 diabetes?
- Covered with prior authorization. Per policy IP0701 (Employer Plans: Standard/Performance, Value/Advantage, Legacy, Total Savings PDLs; covers Bydureon BCise, Byetta/exenatide, Mounjaro, Ozempic tablets+injection, Rybelsus, Trulicity, Victoza/liraglutide). See the full source-cited criteria above. Per Cigna Coverage Policies IP0206 (Weight Loss GLP-1) & IP0701 (Diabetes GLP-1 Employer Plans), as of 2026 (IP0206 eff. 06/01/2026; IP0701 eff. 06/15/2026) — confirm the member's current plan policy.
d3rx does not hold plan-specific pharmacy formularies or PBM prior-auth grids, so it cannot confirm a particular plan's GLP-1 coverage, tier, or PA criteria. The guidance below is the general, source-cited rule; confirm the specific plan's pharmacy formulary / PA policy for a binding answer.
Check Rybelsus for another payer — or draft the PA
Run Rybelsus + any payer in the GLP-1 PA lookup, or have Ask D3 draft a Cigna-ready prior-authorization request with the right criteria and codes — free, no signup.